These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

528 related items for PubMed ID: 9129895

  • 1. Long-term effects of dual chamber pacing in patients with hypertrophic cardiomyopathy without outflow tract obstruction at rest.
    Gadler F, Linde C, Juhlin-Dannfelt A, Ribeiro A, Rydén L.
    Eur Heart J; 1997 Apr; 18(4):636-42. PubMed ID: 9129895
    [Abstract] [Full Text] [Related]

  • 2. Influence of right ventricular pacing site on left ventricular outflow tract obstruction in patients with hypertrophic obstructive cardiomyopathy.
    Gadler F, Linde C, Juhlin-Dannfeldt A, Ribeiro A, Rydén L.
    J Am Coll Cardiol; 1996 Apr; 27(5):1219-24. PubMed ID: 8609346
    [Abstract] [Full Text] [Related]

  • 3. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy.
    Fananapazir L, Epstein ND, Curiel RV, Panza JA, Tripodi D, McAreavey D.
    Circulation; 1994 Dec; 90(6):2731-42. PubMed ID: 7994815
    [Abstract] [Full Text] [Related]

  • 4. Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and beta-adrenergic blocker therapy.
    Fananapazir L, Cannon RO, Tripodi D, Panza JA.
    Circulation; 1992 Jun; 85(6):2149-61. PubMed ID: 1350522
    [Abstract] [Full Text] [Related]

  • 5. Altered cardiac hemodynamic and electrical state in normal sinus rhythm after chronic dual-chamber pacing for relief of left ventricular outflow obstruction in hypertrophic cardiomyopathy.
    McAreavey D, Fananapazir L.
    Am J Cardiol; 1992 Sep 01; 70(6):651-6. PubMed ID: 1510015
    [Abstract] [Full Text] [Related]

  • 6. Rapid return of left ventricular outflow tract obstruction and symptoms following cessation of long-term atrioventricular synchronous pacing for obstructive hypertrophic cardiomyopathy.
    Gadler F, Linde C, Rydén L.
    Am J Cardiol; 1999 Feb 15; 83(4):553-7. PubMed ID: 10073860
    [Abstract] [Full Text] [Related]

  • 7. Comparison of dual-chamber pacing with nonsurgical septal reduction effect in patients with hypertrophic obstructive cardiomyopathy.
    Dimitrow PP, Podolec P, Grodecki J, Płazak W, Dudek D, Pieniazek P, Bacior B, Legutko J, Olszowska M, Kostkiewicz M, Kawecka-Jaszcz K, Tracz W, Dubiel JS.
    Int J Cardiol; 2004 Mar 15; 94(1):31-4. PubMed ID: 14996471
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Is surgery the gold standard in the treatment of obstructive hypertrophic cardiomyopathy?
    Knyshov G, Lazoryshynets V, Rudenko K, Kravchuk B, Beshlyaga V, Zalevsky V, Rasputnyak O, Batsak B.
    Interact Cardiovasc Thorac Surg; 2013 Jan 15; 16(1):5-9. PubMed ID: 23027595
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Paradoxical response to exercise in asymptomatic hypertrophic cardiomyopathy: a new description of outflow tract obstruction dynamics.
    Lafitte S, Reant P, Touche C, Pillois X, Dijos M, Arsac F, Peyrou J, Montaudon M, Ritter P, Roudaut R, Demaria A.
    J Am Coll Cardiol; 2013 Aug 27; 62(9):842-50. PubMed ID: 23810875
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The importance of ventricular septal morphology in the effectiveness of dual chamber pacing in hypertrophic obstructive cardiomyopathy.
    Dimitrow PP, Grodecki J, Bacior B, Dudek D, Legutko J, Jaszcz KK, Dubiel JS.
    Pacing Clin Electrophysiol; 2000 Sep 27; 23(9):1324-9. PubMed ID: 11025886
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. DDD pacing in hypertrophic cardiomyopathy: a multicentre clinical experience.
    Slade AK, Sadoul N, Shapiro L, Chojnowska L, Simon JP, Saumarez RC, Dodinot B, Camm AJ, McKenna WJ, Aliot E.
    Heart; 1996 Jan 27; 75(1):44-9. PubMed ID: 8624871
    [Abstract] [Full Text] [Related]

  • 17. [Long-term beneficial effect of dual chamber pacing in a patient with hypertrophic obstructive cardiomyopathy].
    Takahashi M, Horinaka S, Takada M, Matsumoto N, Tsuchiya N, Yabe A, Onoda M, Murate J, Masuda T, Ishikawa K, Takeda K, Matsuoka H.
    J Cardiol; 1997 Jun 27; 29(6):345-52. PubMed ID: 9211094
    [Abstract] [Full Text] [Related]

  • 18. Placebo effect of pacemaker implantation in obstructive hypertrophic cardiomyopathy. PIC Study Group. Pacing In Cardiomyopathy.
    Linde C, Gadler F, Kappenberger L, Rydén L.
    Am J Cardiol; 1999 Mar 15; 83(6):903-7. PubMed ID: 10190407
    [Abstract] [Full Text] [Related]

  • 19. Non-surgical myocardial reduction in hypertrophic obstructive cardiomyopathy.
    Mutlak D, Gruberg L, Reisner S, Markiewicz W.
    Isr Med Assoc J; 2002 Feb 15; 4(2):86-90. PubMed ID: 11875998
    [Abstract] [Full Text] [Related]

  • 20. Hypertensive left ventricular hypertrophy with left ventricular outflow tract obstructive physiology: a case of successful treatment with dual-chamber pacing.
    Wicks AB, Stajduhar K, Mascette A.
    Mil Med; 1998 Dec 15; 163(12):861-3. PubMed ID: 9866370
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.